The caspase-9 derived C-terminal fragment of cytokeratin 18 modulates topoisomerase action

International Journal of Oncology

Volumn 35, Issue 3, 2009, Pages 625-630

  Schutte, Bert ^a   Henfling, M E R ^a   Verheyen, F K C P ^a   Li, G ^b   Tolstonog, G V ^b   Ramaekers, F C S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Apoptosis; C terminal peptide; Caspase cleavage; Chromatin condensation; Cytokeratin 18; M30 CytoDeath; Nucleolus; Topoisomerase I

Indexed keywords

CASPASE 3; CASPASE 9; CYTOKERATIN 18; DNA TOPOISOMERASE; PLASMID DNA;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; RNA PROCESSING; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

APOPTOSIS; CASPASE 9; CELL LINE, TUMOR; CELL NUCLEOLUS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA FRAGMENTATION; DNA TOPOISOMERASES, TYPE I; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; KERATIN-18; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDE FRAGMENTS; TRANSCRIPTION, GENETIC;

EID: 70349138494     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000374     Document Type: Article

References (37)

1. Nicholson DW: Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6: 1028-1042, 1999.
2. Caulin C, Salvesen GS and Oshima RG: Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138: 1379-1394, 1997.
3. Schutte B, Henfling M, Kölgen W, et al: Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res 297: 11-26, 2004.
4. Byun Y, Chen F, Chang R, Trivedi M, Green KJ and Cryns VL: Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 8: 443-450, 2001.
5. Chen F, Chang R, Trivedi M, Capetanaki Y and Cryns VL: Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J Biol Chem 278: 6848-6853, 2003.
6. Leers MP, Kölgen W, Björklund V, et al: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187: 567-572, 1999.
7. Marceau N, Schutte B, Gilbert S, et al: Dual roles of intermediate filaments in apoptosis. Exp Cell Res (Special Issue - Intermediate Filaments) 313: 2265-2281, 2007.
8. Broers JLV, Bronnenberg NM, Kuijpers HJ, Schutte B, Hutchison CJ and Ramaekers FCS: Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. Eur J Cell Biol 81: 677-691, 2002.
9. Ruchaud S, Korfali N, Villa P, Kottke TJ, Dingwall C, Kaufmann SH and Earnshaw WC: Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J 21: 1967-1977, 2002.
10. Clem RJ, Sheu T-T, Richter BWM, He W-W, Thornberry NA, Duckett CS and Hardwick JM: c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J Biol Chem 276: 7602-7608, 2001.
11. Shoeman RL, Huttermann C, Hartig R and Traub P: Aminoterminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells. Mol Biol Cell 12: 143-154, 2001.
12. Li G, Tolstonog GV, Sabasch M and Traub P: Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities. DNA Cell Biol 21: 743-769, 2002.
13. Widlak P, Li P, Wang X and Garrard WT: Cleavage preferences of the apoptotic endonuclease DFF40 (Caspase-activated DNase or nuclease) on naked DNA and chromatin substrates. J Biol Chem 275: 8226-8232, 2000.
14. Kuhn S, Vorgias CE and Traub P: Interaction in vitro of non-epithelial intermediate filament proteins with supercoiled plasmid DNA. J Cell Sci 87: 543-554, 1987.
15. Hartig R, Shoeman R, Janetzko A, Tolstonog G and Traub P: DNA-mediated transport of the intermediate filament protein vimentin into the nucleus of cultured cells. J Cell Sci 111: 3573-3584, 1998.
16. Olinski R, Wedrychowski A, Schmidt WN, Briggs RC and Hnilica LS: In vivo DNA-protein cross-linking by cis- and trans-diamminedichloroplatinum(II). Cancer Res 47: 201-205, 1987.
17. Spencer VA, Coutts AS, Samuel SK, Murphy LC and Davie JR: Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem 273: 29093-29097, 1998.
18. Spencer VA, Samuel SK and Davie JR: Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines. Cancer Res 60: 288-292, 2000.
19. Akama K, Kondo M, Sato H and Nakano M: Transition protein 4 from boar late spermatid nuclei is a topological factor that stimulates DNA-relaxing activity of topoisomerase I. FEBS Lett 442: 189-192, 1999.
20. Srivenugopal KS and Morris DR: Differential modulation by spermidine of reactions catalyzed by type 1 prokaryotic and eukaryotic topoisomerases. Biochemistry 24: 4766-4771, 1985.
21. Holwitt EA, Koda E and Swenberg CE: Enhancement of topoisomerase I-mediated unwinding of supercoiled DNA by the radioprotector WR-33278. Radiat Res 124: 107-109, 1990.
22. Zechiedrich EL and Osheroff N: Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J 9: 4555-4562, 1990.
23. Chen AY, Yu C, Gatto B and Liu LF: DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Natl Acad Sci USA 90: 8131-8135, 1993.
24. Bell A, Kittler L, Lober G and Zimmer C: DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction. J Mol Recognit 10: 245-255, 1997.
25. Deng H, Bloomfield VA, Benevides JM and Thomas GJ Jr: Structural basis of polyamine-DNA recognition: spermidine and spermine interactions with genomic B-DNAs of different GC content probed by Raman spectroscopy. Nucleic Acids Res 28: 3379-3385, 2000.
26. Li G, Tolstonog GV, Sabasch M and Traub P: Type III intermediate filament proteins interact with four-way junction DNA and facilitate its cleavage by the junction-resolving enzyme T7 endonuclease I. DNA Cell Biol 22: 261-291, 2003.
27. Balhorn R, Brewer L and Corzett M: DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules. Mol Reprod Dev 56 (Suppl. 2): S230-S234, 2000.
28. Keller M, Tagawa T, Preuss M and Miller AD: Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu. Biochemistry 41: 652-659, 2002.
29. Brewer L, Corzett M and Balhorn R: Condensation of DNA by spermatid basic nuclear proteins. J Biol Chem 277: 38895-38900, 2002.
30. Leppard JB and Champoux JJ: Human DNA topoisomerase I: relaxation, roles, and damage control. Chromosoma 114: 75-85, 2005.
31. Christensen MO, Krokowski RM, Barthelmes HU, Hock R, Boege F and Mielke C: Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I. J Biol Chem 279: 21873-21882, 2004.
32. Zhang H, Wang JC and Liu LF: Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci USA 85: 1060-1064, 1988.
33. Soe K, Rockstroh A, Schache P and Grosse F: The human topoisomerase I damage response plays a role in apoptosis. DNA Repair 3: 387-393, 2004.
34. Samejima K, Svingen PA, Basi GS, et al: Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J Biol Chem 274: 4335-4340, 1999.
35. Sirri V, Hernandez-Verdun D and Roussel P: Cyclin-dependent kinases govern formation and maintenance of the nucleolus. J Cell Biol 156: 969-981, 2002.
36. Schlosser I, Holzel M, Murnseer M, Burtscher H, Weidle UH and Eick D: A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Res 31: 6148-6156, 2003.
37. Ayrault O, Andrique L, Larsen CJ and Seite P: Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes. Oncogene 23: 8097-8104, 2004.